Description
"Other" represents a non-specific category encompassing various therapeutic agents used in colorectal cancer treatment that do not fit into standard drug classifications. Based on the clinical trial context, this likely includes dose-modified chemotherapy regimens, combination protocols, or supportive care interventions used in neoadjuvant therapy for locally advanced rectal cancer. These agents are typically employed as part of multimodal treatment approaches, particularly in elderly patients or those requiring organ preservation strategies.
Mechanism of Action
The mechanism of action varies depending on the specific agent or intervention classified under this category. Many involve DNA damage through alkylation or antimetabolite pathways when referring to modified chemotherapy protocols. The molecular targets and pathways differ based on the individual components of the treatment regimen.
Molecular Targets
Side Effects
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.